Atara Biotherapeutics's Earnings: A Preview

Atara Biotherapeutics ATRA is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement.

Analysts estimate that Atara Biotherapeutics will report an earnings per share (EPS) of $-0.78.

Atara Biotherapeutics bulls will hope to hear the company to announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Past Earnings Performance

Last quarter the company beat EPS by $0.62, which was followed by a 29.2% increase in the share price the next day.

Here's a look at Atara Biotherapeutics's past performance and the resulting price change:

Quarter Q2 2022 Q1 2022 Q4 2021 Q3 2021
EPS Estimate -0.93 -0.98 -0.69 -0.94
EPS Actual -0.31 -0.87 -0.96 -0.90
Price Change % 29.2% 1.47% -20.54% -8.65%

eps graph

Stock Performance

Shares of Atara Biotherapeutics were trading at $4.75 as of November 04. Over the last 52-week period, shares are down 73.34%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release.

To track all earnings releases for Atara Biotherapeutics visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-EP
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!